Cell & Gene Therapy Drug Delivery Devices Market Forecasts 14% CAGR Growth Through 2028

0
45
Cell & Gene Therapy Drug Delivery Devices Market

Global Cell & Gene Therapy Drug Delivery Devices Market Insights Report Overview

Dive into the latest insights on the Global Cell & Gene Therapy Drug Delivery Devices Market with our comprehensive report, accurately curated by the experts at MarkNtel Advisors. Our report offers a thorough examination of the global landscape, providing valuable data, impartial analysis, and strategic insights to drive informed decision-making.

Report’s Study Period:

  • Historical Period: 2018-21
  • Base Year: 2022
  • Forecasting Period: 2023-28

We accurately gather data from primary and secondary sources, capturing the industry’s historical fluctuations and trends, including market dynamics, consumer behavior, manufacturing insights, and more. Leveraging this data alongside the base year information, we project the industry’s trajectory into the future.

In case you missed it, we are currently revising our reports. Click on the “request Sample report” button to get the latest research data with forecast for the years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Industry Driving Factor:

  • Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
  • Mounting prevalence of genetic disorders & chronic diseases
  • An increasing number of FDA approvals for cell & gene therapies & their clinical trials

Segmentation Summary: Global Cell & Gene Therapy Drug Delivery Devices Market

Our report delves into the intricate segmentation of the Cell & Gene Therapy Drug Delivery Devices Market, providing insights into each subdivision’s trajectory, trends, and advancements. This analysis empowers stakeholders to navigate the industry landscape with precision, understanding the nuances of each segment.

-By Commercialized Drugs

  • Luxturna
  • Kymriah
  • Yescarta
  • Zolgensma
  • Provenge
  • Strimvelis

Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2021.

Luxturna (voretigene neparvovec-rzyl) is an Adeno-Associated Virus (AAV) vector-based gene therapy. It is for the treatment of patients with confirmed biallelic RPE65 mutation-associated Inherited Retinal Dystrophy (IRD), which causes vision loss and even complete blindness in some patients.

This therapy has improved patients’ vision & their ability to move around obstructions, especially in low light, which is a crucial clinical advantage, reckoning the lack of legitimate treatments for this condition. Moreover, it shows acceptable safety levels and manageable side effects. Hence, owing to more benefits than risks associated with Luxturna, its demand is rapidly increasing worldwide.

-By Product Type

  • Sub-retinal Injection Cannula
  • Extension Tube
  • Intravenous Catheter
  • Sterile Insulin Syringe
  • Pre-Filled Syringe
  • Infusion Bags

-By Technology

  • Microchip Technology
  • Nano-Technology
  • Lipid Nanoparticles

-By End-User

  • Pharmaceuticals & Biotechnology Company
  • Academic & Research Institute
  • Hospitals & Clinics

Read Full Report -  https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Leading Competitor: Global Cell & Gene Therapy Drug Delivery Devices Market

  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Becton, Dickinson and Company
  • Bluebird bio Inc.
  • Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
  • Dendreon Pharmaceuticals LLC
  • Helixmith Co. Ltd (ViroMed Co., Ltd)
  • Human Stem Cells Institute
  • Kite Pharma Inc.
  • Kolon TissueGene, Inc.
  • Novartis AG
  • Orchard Therapeutics plc.
  • Pfizer Inc.
  • Renova Therapeutics
  • Spark Therapeutics Inc.
  • uniQure N.V.
  • Vericel Corporation

Geographical Reach:

The Cell & Gene Therapy Drug Delivery Devices Industry spans across various regions, each characterized by unique cultural, regulatory, and economic factors. Our regional analysis provides a comprehensive overview and forecast, considering these differences and assessing market players’ presence, consumer preferences, and more.

-By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

For inquiries or further discussions, connect with our analyst today to unlock the full potential of the Cell & Gene Therapy Drug Delivery Devices Industry.

Request Customization – https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html

Key Focus Areas:

  • What are the primary drivers and trends influencing the Cell & Gene Therapy Drug Delivery Devices Industry’s growth, and how is the market structured?
  • How are segments within the Cell & Gene Therapy Drug Delivery Devices Industry defined, and what is the size of each segment?
  • Which segments and geographical regions present the most promising growth opportunities?
  • What does the competitive landscape look like, and how do key players position themselves within the market?

More Reports:

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

Media Representative

Company Name: MarkNtel Advisors

Email: sales@marknteladvisors.com

Phone: +1 628 895 8081, +91 120 4278433

Leave a reply